索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]钟豪轩 罗心平.模式识别受体NOD2在心血管疾病中的研究进展[J].国际心血管病杂志,2019,04:226-229.
点击复制

模式识别受体NOD2在心血管疾病中的研究进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2019年04期
页码:
226-229
栏目:
综述
出版日期:
2019-09-27

文章信息/Info

Title:
-
作者:
钟豪轩 罗心平
200032 上海,复旦大学华山医院心血管内科
Author(s):
-
关键词:
核苷酸结合寡聚化结构域2;  心血管疾病;  血栓;  Toll样受体
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2019.04.010
文献标识码:
-
摘要:
核苷酸结合寡聚化结构域2(NOD2)属于NOD样受体家族,作为一种胞内模式识别受体,NOD2通过识别配体胞壁酰二肽参与宿主细胞对病原体的识别,介导免疫炎性反应。近年来研究发现,NOD2在心肌炎、动脉粥样硬化、心肌梗死等多种心血管疾病的发生发展过程中发挥重要作用。该文介绍NOD2在心血管疾病中的研究进展。
Abstract:
-

参考文献/References

[ 1 ] Strober W, Murray PJ, Kitani A, et al. Signalling pathways and molecular interactions of NOD1 and NOD2[J]. Nat Rev Immunol, 2006, 6(1):9-20.
[ 2 ] Mcgovern DP, van Heel DA, Ahmad T, et al. NOD2(CARD15), the first susceptibility gene for Crohn's disease[J]. Gut, 2001, 49(6):752-754.
[ 3 ] Tschöpe C, Muller I, Xia Y, et al. NOD2(nucleotide-binding oligomerization domain 2)is a major pathogenic mediator of Coxsackievirus B3-induced myocarditis[J]. Circ Heart Fail, 2017, 10(9):e003870.
[ 4 ] Miteva K, Pappritz K, Sosnowski M, et al. Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of coxsackievirus B3-induced inflammatory cardiomyopathy[J]. Sci Rep, 2018, 8(1):2820.
[ 5 ] Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy[J]. J Mol Cell Cardiol, 2016, 97(1):245-262.
[ 6 ] Zong J, Salim M, Zhou H, et al. NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload[J]. Lab Invest, 2013, 93(10):1128-1136.
[ 7 ] Tsai WH, Huang DY, Yu YH, et al. Dual roles of NOD2 in TLR4-mediated signal transduction and -induced inflammatory gene expression in macrophages[J]. Cell Microbiol, 2011, 13(5):717-730.
[ 8 ] Richardson WM, Sodhi CP, Russo A, et al. Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium[J]. Gastroenterology, 2010, 139(3):904-917.
[ 9 ] Watanabe T, Kitani A, Murray PJ, et al. Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis[J]. Immunity, 2006, 25(3):473-485.
[10] Higashikuni Y, Tanaka K, Kato M, et al. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1βupregulation via nuclear factor kB activation[J]. J Am Heart Assoc, 2013, 2(6):e000267.
[11] Shen L, Li L, Li M, et al. Silencing of NOD2 protects against diabetic cardiomyopathy in a murine diabetes model[J]. Int J Mol Med, 2018, 42(6):3017-3026.
[12] Shiny A, Regin B, Balachandar V, et al. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain(NOD)expression and signaling in monocytes from patients with type 2 diabetes[J]. Cytokine, 2013, 64(2):564-570.
[13] Tian DY, Jin XR, Zeng X, et al. Notch signaling in endothelial cells: is it the therapeutic target for vascular neointimal hyperplasia?[J]. Int J Mol Sci, 2017, 18(8):e1615.
[14] Li PC, Sheu MJ, Ma WF, et al. Anti-restenotic roles of dihydroaustrasulfone alcohol involved in inhibiting PDGF-BB-stimulated proliferation and migration of vascular smooth muscle cells[J]. Mar Drugs, 2015, 13(5):3046-3060.
[15] Kwon MY, Liu X, Lee SJ, et al. Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injury[J]. Arterioscler Thromb Vasc Biol, 2011, 31(11):2441-2447.
[16] Zhang LL, Gao CY, Fang CQ, et al. PPARγ intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells[J]. Cardiovasc Res, 2011, 92(3):484-493.
[17] Liu Q, Li JP, Liang QL, et al. Sparstolonin B suppresses rat vascular smooth muscle cell proliferation, migration, inflammatory response and lipid accumulation[J]. Vascul Pharmacol, 2015, 67-69:59-66.
[18] Kobayashi N, Suzuki J, Ogawa M, et al. Porphyromonas gingival is promotes neointimal formation after arterial injury through toll-like receptor 2 signaling[J]. Heart Vessels, 2014, 29(4):542-549.
[19] Kobayashi N, Suzuki JI, Aoyama N, et al. Toll-like receptor 4 signaling has a critical role in Porphyromonasgingivalis-accelerated neointimal formation after arterial injury in mice[J]. Hypertens Res, 2016, 39(10):717-722.
[20] Kwon MY, Hwang N, Park YJ, et al. NOD2 deficiency exacerbates hypoxia-induced pulmonary hypertension and enhances pulmonary vascular smooth muscle cell proliferation[J]. Oncotarget, 2018, 9(16):12671-12681.
[21] Yuan HP, Zelka S, Burkatovskaya M, et al. Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss[J]. Proc Natl Acad Sci U S A, 2013, 110(52):e5059-e5068.
[22] Pan S, Lei L, Chen S, et al. Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice[J]. Int Immunopharmacol, 2014, 23(2):701-708.
[23] Levin MC, Jirholt P, Wramstedt A, et al. Rip2 deficiency leads to increased atherosclerosis despite decreased inflammation[J]. Circ Res, 2011, 109(11):1210-1218.
[24] Johansson ME, Zhang XY, Edfeldt KA, et al. Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice[J]. Eur J Immunol, 2014, 44(10):3081-3092.
[25] Frangogiannis NG. Regulation of the inflammatory response in cardiac repair[J]. Circ Res, 2012, 110(1):159-173.
[26] Li X, Li F, Chu Y, et al. NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice[J]. Cell Physiol Biochem, 2013, 32(6):1857-1866.
[27] Zhang H, Zhu T, Liu W, et al. TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury[J]. J Mol Med(Berl), 2015, 93(9):1033-1043.
[28] Liu Y, Yang H, Liu LX, et al. NOD2 contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and inflammation[J]. Life Sci, 2016, 149:10-17.
[29] Shigeoka AA, Kambo A, Mathison JC, et al. Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury[J]. J Immunol, 2010, 184(5):2297-2304.
[30] Wang YH, Chen KM, Chiu PS, et al. Lumbrokinase attenuates myocardial ischemia-reperfusion injury by inhibiting TLR4 signaling[J]. J Mol Cell Cardiol, 2016, 99:113-122.
[31] Zhang Y, Shao Z, Zhang X, et al. TIPE2 play a negative role in TLR4-mediated autoimmune T helper 17 cell responses in patients with myasthenia gravis[J]. J Neuroimmune Pharmacol, 2015, 10(4):635-644.
[32] O'neill S, Humphries D, Tse G, et al. Heat shock protein 90 inhibition abrogates TLR4-mediated NF-κB activity and reduces renal ischemia-reperfusion injury[J]. Sci Rep, 2015, 5:12958.
[33] Lee KH, Biswas A, Liu YJ, et al. Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components[J]. J Biol Chem, 2012, 287(47):39800-39811.
[34] Mayor A, Martinon F, De Smedt T, et al. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses[J]. Nat Immunol, 2007, 8(5):497-503.
[35] Zhang S, Zhang S, Hu L, et al. Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis[J]. Circulation, 2015, 131(13):1160-1170.
[36] Caruso R, Warner N, Inohara N, et al. NOD1 and NOD2: signaling, host defense, and inflammatory disease[J]. Immunity, 2014, 41(6):898-908.
[37] Kim YG, Park JH, Shaw MH, et al. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to toll-like receptor ligands[J]. Immunity, 2008, 28(2):246-257.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81770348)
作者单位:200032 上海,复旦大学华山医院心血管内科
通信作者:罗心平,Email:luoxp2007@aliyun.com
更新日期/Last Update: 2019-09-27